Catheter-related bacteremia caused by methicillin-resistant coagulase negative staphylococci with elevated minimal inhibitory concentration for vancomycin

Pediatric Infectious Disease Journal

Volumn 29, Issue 11, 2010, Pages 1047-1048

  Castagnola, Elio ^a   Bandettini, Roberto ^b   Lorenzi, Ines ^c   Caviglia, Ilaria ^a   MacRina, Gianni ^a   Tacchella, Angela ^a  

^a G GASLINI INSTITUTE   (Italy)

^b Laboratory of Microbiology   (Italy)

^c Department of Pharmacy ^*  (Italy)

Author keywords

coagulasenegative staphylococci; daptomycin; linezolid; Pediatrics; vancomycin

Indexed keywords

DAPTOMYCIN; LINEZOLID; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BLOOD CULTURE; CANCER CHEMOTHERAPY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; EPSILOMETER TEST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 78149282784     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181e8b74d     Document Type: Article

References (12)

1. Fratino G, Molinari AC, Parodi S, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol. 2005;16:648-654.
2. Viscoli C, Castagnola E. Prophylaxis and Empirical Therapy of Infection in Cancer Patients. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone Elsevier; 2010:3793-3807.
3. Pinon M, Bezzio S, Tovo PA, et al. A prospective 7-year survey on central venous catheter-related complications at a single pediatric hospital. Eur J Pediatr. 2009;168:1505-1512.
4. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1-45.
5. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian association of paediatric haematology and oncology. Supportive therapy groupinfectious diseases section. Eur J Cancer. 1999;35:770-774.
6. Castagnola E, Moroni C, Gandullia P, et al. Catheter lock and systemic infusion of linezolid for treatment of persistent broviac catheter-related staphylococcal bacteremia. Antimicrob Agents Chemother. 2006;50:1120-1121.
7. Kaplan SL, Deville JG, Yogev R, et al. Linezolid versus vancomycin for treatment of resistant gram-positive infections in children. Pediatr Infect Dis J. 2003;22:677-686.
8. Ardura MI, Mejias A, Katz KS, et al. Daptomycin therapy for invasive gram-positive bacterial infections in children. Pediatr Infect Dis J. 2007;26:1128-1132.
9. Tavil B, Balci YI, Yildirim I, et al. Linezolid-induced reversible bicytopenia in a 4-year-old boy with methicillin-resistant Staphylococcus aureus bacteremia. Pediatr Hematol Oncol. 2008;25:67-71.
10. Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009;28:398-402.
11. Frymoyer A, Hersh AL, Coralic Z, et al. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. Clin Ther. 2010;32:534-542.
12. Robinson JL, Tawfik G, Roth A. Barriers to antibiotic lock therapy in children with intravascular catheter-related bloodstream infections. Pediatr Infect Dis J. 2005;24:944.